116 related articles for article (PubMed ID: 22388168)
1. Atomoxetine for encopresis in 2 children with attention-deficit/hyperactivity disorder.
Hergüner S; Hergüner A
J Clin Psychopharmacol; 2012 Apr; 32(2):302-3. PubMed ID: 22388168
[No Abstract] [Full Text] [Related]
2. Increased Frequency of Encopresis in a Child Diagnosed With Attention Deficit/Hyperactivity Disorder and Encopresis After Atomoxetine Use: A Case Report.
Yektaş Ç; Cansiz MA; Tufan AE
Clin Neuropharmacol; 2016; 39(4):212-3. PubMed ID: 27332628
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Atomoxetine in the Treatment of Children With Encopresis.
Türkoğlu S; Bilgiç A; Uzun N
J Clin Psychopharmacol; 2015 Oct; 35(5):622-3. PubMed ID: 26110671
[No Abstract] [Full Text] [Related]
4. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder.
Bangs ME; Hazell P; Danckaerts M; Hoare P; Coghill DR; Wehmeier PM; Williams DW; Moore RJ; Levine L;
Pediatrics; 2008 Feb; 121(2):e314-20. PubMed ID: 18245404
[TBL] [Abstract][Full Text] [Related]
5. [Atomoxetine Treatment For Encopresis In A Child With Attention Deficit Hyperactivity Disorder].
Bozkurt H; Şahin S
Turk Psikiyatri Derg; 2016; 27(2):0. PubMed ID: 27482753
[TBL] [Abstract][Full Text] [Related]
6. Atomoxetine in the treatment of attention deficit hyperactivity disorder.
Kratochvil CJ; Vaughan BS; Daughton JM; Mayfield-Jorgensen ML; Burke WJ
Expert Rev Neurother; 2004 Jul; 4(4):601-11. PubMed ID: 15853579
[TBL] [Abstract][Full Text] [Related]
7. Once-daily treatment with atomoxetine in adults with attention-deficit/hyperactivity disorder: a 24-week, randomized, double-blind, placebo-controlled trial.
Young JL; Sarkis E; Qiao M; Wietecha L
Clin Neuropharmacol; 2011; 34(2):51-60. PubMed ID: 21406998
[TBL] [Abstract][Full Text] [Related]
8. An open-label, dose-titration tolerability study of atomoxetine hydrochloride in Japanese adults with attention-deficit/hyperactivity disorder.
Takahashi M; Takita Y; Goto T; Ichikawa H; Saito K; Matsumoto H; Tanaka Y
Psychiatry Clin Neurosci; 2011 Feb; 65(1):55-63. PubMed ID: 21265936
[TBL] [Abstract][Full Text] [Related]
9. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
Niederhofer H
Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351
[No Abstract] [Full Text] [Related]
10. Atomoxetine.
Unni JC
Indian Pediatr; 2006 Jul; 43(7):603-6. PubMed ID: 16891679
[No Abstract] [Full Text] [Related]
11. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
12. Effects of atomoxetine on cardiovascular functions and on QT dispersion in children with attention deficit hyperactivity disorder.
Sert A; Gokcen C; Aypar E; Odabas D
Cardiol Young; 2012 Apr; 22(2):158-61. PubMed ID: 21864451
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind comparison of atomoxetine and placebo on response inhibition and interference control in children and adolescents with autism spectrum disorder and comorbid attention-deficit/hyperactivity disorder symptoms.
van der Meer JM; Harfterkamp M; van de Loo-Neus G; Althaus M; de Ruiter SW; Donders AR; de Sonneville LM; Buitelaar JK; Hoekstra PJ; Rommelse NN
J Clin Psychopharmacol; 2013 Dec; 33(6):824-7. PubMed ID: 24018545
[No Abstract] [Full Text] [Related]
14. Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands.
Sasané R; Hodgkins P; Meijer W
Curr Med Res Opin; 2010 Nov; 26(11):2565-74. PubMed ID: 20863165
[TBL] [Abstract][Full Text] [Related]
15. Comparison of parent and teacher reports of attention-deficit/hyperactivity disorder symptoms from two placebo-controlled studies of atomoxetine in children.
Biederman J; Gao H; Rogers AK; Spencer TJ
Biol Psychiatry; 2006 Nov; 60(10):1106-10. PubMed ID: 16806096
[TBL] [Abstract][Full Text] [Related]
16. [Atomoxetine (strattera) in the treatment of attention deficit hyperactivity syndrome].
Ershova A
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(10):87-91. PubMed ID: 19097312
[No Abstract] [Full Text] [Related]
17. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
[TBL] [Abstract][Full Text] [Related]
18. Effect of atomoxetine on executive function impairments in adults with ADHD.
Brown TE; Holdnack J; Saylor K; Adler L; Spencer T; Williams DW; Padival AK; Schuh K; Trzepacz PT; Kelsey D
J Atten Disord; 2011 Feb; 15(2):130-8. PubMed ID: 20026871
[TBL] [Abstract][Full Text] [Related]
19. Atomoxetine for attention deficit hyperactivity disorder in mental retardation.
Fernández-Jaén A; Fernández-Mayoralas DM; Calleja Pérez B; Muñoz Jareño N; Campos Díaz Mdel R
Pediatr Neurol; 2010 Nov; 43(5):341-7. PubMed ID: 20933178
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind study of continuation treatment for attention-deficit/hyperactivity disorder after 1 year.
Buitelaar JK; Michelson D; Danckaerts M; Gillberg C; Spencer TJ; Zuddas A; Faries DE; Zhang S; Biederman J
Biol Psychiatry; 2007 Mar; 61(5):694-9. PubMed ID: 16893523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
